SWCAX | VCADX | SWCAX / VCADX | |
Total Expense Ratio | 0.38 | 0.09 | 422% |
Annual Report Gross Expense Ratio | 0.41 | 0.09 | 456% |
Fund Existence | 34 years | 24 years | - |
Gain YTD | 2.660 | 1.674 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 496M | 17.4B | 3% |
Annual Yield % from dividends | 3.20 | 3.02 | 106% |
Returns for 1 year | 2.36 | 0.44 | 542% |
Returns for 3 years | 12.97 | 6.38 | 203% |
Returns for 5 years | 2.46 | -5.53 | -45% |
Returns for 10 years | 14.44 | -1.64 | -880% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QID | 21.53 | 0.16 | +0.75% |
ProShares UltraShort QQQ | |||
BIS | 11.73 | 0.08 | +0.72% |
ProShares UltraShort Nasdaq Biotech | |||
FIXP | 19.80 | N/A | N/A |
FolioBeyond Enhanced Fixed Inc Prm ETF | |||
FTC | 159.69 | -1.66 | -1.03% |
First Trust Large Cap Gr AlphaDEX® ETF | |||
VAMO | 33.04 | -0.62 | -1.84% |
Cambria Value and Momentum ETF |